235 related articles for article (PubMed ID: 9561995)
1. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction.
Grines CL; Marsalese DL; Brodie B; Griffin J; Donohue B; Costantini CR; Balestrini C; Stone G; Wharton T; Esente P; Spain M; Moses J; Nobuyoshi M; Ayres M; Jones D; Mason D; Sachs D; Grines LL; O'Neill W
J Am Coll Cardiol; 1998 Apr; 31(5):967-72. PubMed ID: 9561995
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators.
Stone GW; Grines CL; Rothbaum D; Browne KF; O'Keefe J; Overlie PA; Donohue BC; Chelliah N; Vlietstra R; Catlin T; O'Neill WW
J Am Coll Cardiol; 1997 Apr; 29(5):901-7. PubMed ID: 9120173
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators.
Stone GW; Marsalese D; Brodie BR; Griffin JJ; Donohue B; Costantini C; Balestrini C; Wharton T; Esente P; Spain M; Moses J; Nobuyoshi M; Ayres M; Jones D; Mason D; Grines L; O'Neill WW; Grines CL
J Am Coll Cardiol; 1997 Jun; 29(7):1459-67. PubMed ID: 9180105
[TBL] [Abstract][Full Text] [Related]
4. Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
Am J Cardiol; 1996 Jul; 78(1):19-25. PubMed ID: 8712112
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study.
Grines CL; Westerhausen DR; Grines LL; Hanlon JT; Logemann TL; Niemela M; Weaver WD; Graham M; Boura J; O'Neill WW; Balestrini C;
J Am Coll Cardiol; 2002 Jun; 39(11):1713-9. PubMed ID: 12039480
[TBL] [Abstract][Full Text] [Related]
6. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators.
Stone GW; Brodie BR; Griffin JJ; Grines L; Boura J; O'Neill WW; Grines CL
J Am Coll Cardiol; 2000 Mar; 35(3):605-11. PubMed ID: 10716461
[TBL] [Abstract][Full Text] [Related]
7. Care of acute myocardial infarction by noninvasive and invasive cardiologists: procedure use, cost and outcome.
Di Salvo TT; Paul SD; Lloyd-Jones D; Smith AJ; Villarreal-Levy G; Bamezai V; Hussain SI; Eagle KA; O'Gara PT
J Am Coll Cardiol; 1996 Feb; 27(2):262-9. PubMed ID: 8557892
[TBL] [Abstract][Full Text] [Related]
8. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
[TBL] [Abstract][Full Text] [Related]
9. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N
J Am Coll Cardiol; 1995 Jul; 26(1):66-72. PubMed ID: 7797777
[TBL] [Abstract][Full Text] [Related]
10. Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry.
Mark DB; O'Neill WW; Brodie B; Ivanhoe R; Knopf W; Taylor G; O'Keefe JH; Grines CL; Davidson-Ray L; Knight JD
J Am Coll Cardiol; 1995 Sep; 26(3):688-95. PubMed ID: 7642860
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of coronary stenting in acute myocardial infarction: results from the stent primary angioplasty in myocardial infarction (stent-PAMI) trial.
Cohen DJ; Taira DA; Berezin R; Cox DA; Morice MC; Stone GW; Grines CL
Circulation; 2001 Dec; 104(25):3039-45. PubMed ID: 11748097
[TBL] [Abstract][Full Text] [Related]
12. Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes.
Kumbhani DJ; Cannon CP; Fonarow GC; Liang L; Askari AT; Peacock WF; Peterson ED; Bhatt DL;
JAMA; 2009 Nov; 302(20):2207-13. PubMed ID: 19934421
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of outcome of primary PTCA for acute myocardial infarction in patients younger and older than 70 years of age].
Santoro GM; Valenti R; Buonamici P; Cerisano G; Bolognese L; Antoniucci D; Fazzini PF
G Ital Cardiol; 1996 Oct; 26(10):1111-22. PubMed ID: 9005157
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial).
Kandzari DE; Tcheng JE; Cohen DJ; Bakhai A; Grines CL; Cox DA; Effron M; Stuckey T; Griffin JJ; Turco M; Carroll JD; Fahy M; Mehran R; Stone GW;
Am J Cardiol; 2003 Oct; 92(7):779-84. PubMed ID: 14516875
[TBL] [Abstract][Full Text] [Related]
15. Acute and long-term cost implications of coronary stenting.
Peterson ED; Cowper PA; DeLong ER; Zidar JP; Stack RS; Mark DB
J Am Coll Cardiol; 1999 May; 33(6):1610-8. PubMed ID: 10334432
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial.
Bakhai A; Stone GW; Grines CL; Murphy SA; Githiora L; Berezin RH; Cox DA; Stuckey T; Griffin JJ; Tcheng JE; Cohen DJ;
Circulation; 2003 Dec; 108(23):2857-63. PubMed ID: 14610016
[TBL] [Abstract][Full Text] [Related]
17. DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction.
Steg PG; Thuaire C; Himbert D; Carrié D; Champagne S; Coisne D; Khalifé K; Cazaux P; Logeart D; Slama M; Spaulding C; Cohen A; Tirouvanziam A; Montély JM; Rodriguez RM; Garbarz E; Wijns W; Durand-Zaleski I; Porcher R; Brucker L; Chevret S; Chastang C;
Eur Heart J; 2004 Dec; 25(24):2187-94. PubMed ID: 15589635
[TBL] [Abstract][Full Text] [Related]
18. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial Infarction.
Rogers WJ; Canto JG; Barron HV; Boscarino JA; Shoultz DA; Every NR
J Am Coll Cardiol; 2000 Feb; 35(2):371-9. PubMed ID: 10676683
[TBL] [Abstract][Full Text] [Related]
19. Effect of reperfusion modality on outcome in nonsmokers and smokers with acute myocardial infarction (a Primary Angioplasty in Myocardial Infarction [PAMI] substudy). PAMI Investigators.
Bowers TR; Terrien EF; O'Neill WW; Sachs D; Grines CL
Am J Cardiol; 1996 Sep; 78(5):511-5. PubMed ID: 8806333
[TBL] [Abstract][Full Text] [Related]
20. Cost advantages of an ad hoc angioplasty strategy.
Adele C; Vaitkus PT; Wells SK; Zehnacker JB
J Am Coll Cardiol; 1998 Feb; 31(2):321-5. PubMed ID: 9462574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
